Relapsing Multiple Scelrosis
1 clinical trials · Condition
◉ Watch Relapsing Multiple Scelrosis
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. (NCT02792231) | Novartis Pharmaceuticals | 2016-08-26 |
Track Relapsing Multiple Scelrosis automatically
Every clearance here is in the API, with alerts when new ones post.